Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Laboratory Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.3700139PMID 14990980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology.

  2002cited by this paper
• Days and Knights Discussing Membrane Dynamics in Endocytosis: Meeting Report from the Euresco/EMBL Membrane Dynamics in Endocytosis, 6–11 October in Tomar, Portugal

  2002cited by this paper
• Monoclonal Light Chain–Mesangial Cell Interactions: Early Signaling Events and Subsequent Pathologic Effects

  2001cited by this paper
• Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice

  2001cited by this paper
• Talin, a host cell protein, interacts directly with the translocated intimin receptor, Tir, of enteropathogenic Escherichia coli, and is essential for pedestal formation

  2001cited by this paper
• Cell biology. Life without caveolae.

  2001cited by this paper
• Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton.

  2000cited by this paper
• Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.

  2000cited by this paper
• Isoforms of caveolin-1 and caveolar structure.

  2000cited by this paper
• The value of electron microscopy in the diagnosis and clinical management of lupus nephritis.

  1999cited by this paper
• Glomerulopathic light chain-mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo.

  1999cited by this paper
• Mutant Rab7 Causes the Accumulation of Cathepsin D and Cation-independent Mannose 6–Phosphate Receptor in an Early Endocytic Compartment

  1998cited by this paper
• The caveolae membrane system.

  1998cited by this paper
• Role of the Small GTPase RAB7 in the Late Endocytic Pathway*

  1997cited by this paper
• Membrane dynamics in endocytosis.

  1996cited by this paper
• Rab4 and Rab7 Define Distinct Nonoverlapping Endosomal Compartments*

  1996cited by this paper
• Caveolae and caveolins.

  1996cited by this paper
• Rab 7: an important regulator of late endocytic membrane traffic

  1995cited by this paper
• The rab7 GTPase resides on a vesicular compartment connected to lysosomes.

  1995cited by this paper
• Monoclonal immunoglobulin light chain-related renal diseases.

  1993cited by this paper
• The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway.

  1992cited by this paper
• Light-chain binding sites on renal brush-border membranes.

  1990cited by this paper
• The contribution of glomerular mesangial cells to progressive glomerulosclerosis.

  1989cited by this paper
• The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.

  1989cited by this paper
• Ultrastructural immunolabeling in renal diseases. Past, present and future expectations.

  1987cited by this paper
• Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo.

  1987cited by this paper
• Improved methods for culturing rat glomerular cells.

  1984cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper

• Proteomic shifts post-plasma cell therapy in AL amyloid plaques and potential implications for light chain-directed anti-fibril monoclonal antibodies

  2025cites this paper
• Identifying gene expression and cellular pathways involved in glomerular AL-amyloidosis and correlation with experimental data: seeking novel therapeutic interventions

  2025cites this paper
• B Cell-Derived and Non-B Cell-Derived Free Light Chains: From Generation to Biological and Pathophysiological Roles

  2025cites this paper
• Monoclonal gammopathy of renal significance from the perspective of nephrologists

  2024cites this paper
• Receptor-mediated endocytosis in kidney cells during physiological and pathological conditions.

  2024cites this paper
• The Cryo-EM structure of renal amyloid fibril suggests structurally homogeneous multiorgan aggregation in AL amyloidosis.

  2023cites this paper
• A widely expressed free immunoglobulin κ chain with a unique Vκ4-1/Jκ3 pattern promotes colon cancer invasion and metastasis by activating the integrin β1/FAK pathway.

  2022cites this paper
• Renal amyloidosis: Pathogenesis

  2021influential citation
• Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling

  2021cites this paper
• An update to the pathogenesis for monoclonal gammopathy of renal significance.

  2020cites this paper
• Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease

  2020cites this paper
• An update to the pathogenesis for monoclonal gammopathy of renal significance

  2020cites this paper
• Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside

  2020cites this paper
• Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells

  2019cites this paper
• Pathophysiology and management of monoclonal gammopathy of renal significance.

  2019cites this paper
• [Modern approaches to the detection of monoclonal gammopathy of undetermined significance (MGUS) in patients with kidney diseases].

  2019cites this paper
• The pathogenesis of renal injury and treatment in light chain deposition disease

  2019cites this paper
• Isolation and purification of recombinant immunoglobulin light chain variable domains from the periplasmic space of Escherichia coli

  2018cites this paper
• Animal models of monoclonal immunoglobulin-related renal diseases

  2018cites this paper
• Immunoglobulin light chain amyloid aggregation.

  2018cites this paper
• Novel Therapies in Light Chain Amyloidosis

  2017cites this paper
• Journal Immunological Methods Free light chains: Eclectic multipurpose biomarker

  2017cites this paper
• The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases.

  2017cites this paper
• Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?

  2017cites this paper
• Free light chains: Eclectic multipurpose biomarker.

  2017cites this paper
• Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis

  2017cites this paper
• Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis

  2017cites this paper
• Healing the damaged mesangium in nodular glomerulosclerosis using mesenchymal stem cells (MSCs): Expectations and challenges

  2016cites this paper
• Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

  2016cites this paper
• Cell Damage in Light Chain Amyloidosis

  2016cites this paper
• Viewing Extrinsic Proteotoxic Stress Through the Lens of Amyloid Cardiomyopathy.

  2016cites this paper
• Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.

  2016cites this paper
• Solid- and Solution-State Nuclear Magnetic Resonance Spectroscopic Analysis of Amyloidogenic Immunoglobulin Light Chains and their Interactions with Epigallocatechin Gallate

  2016cites this paper
• Amyloid Nephropathy: A Practical Diagnostic Approach and Review on Pathogenesis

  2016cites this paper
• Animal Models of Light Chain Deposition Disease Provide a Better Understanding of Nodular Glomerulosclerosis

  2016cites this paper
• [Kidney injury associated with monoclonal gammopathies: Perspectives on diagnosis and treatment].

  2015cites this paper
• Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes

  2015cites this paper
• [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].

  2015cites this paper
• New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.

  2015cites this paper
• Renal Amyloidosis.

  2014cites this paper
• Extrusion of Amyloid Fibrils to the Extracellular Space in Experimental Mesangial AL-Amyloidosis: Transmission and Scanning Electron Microscopy Studies and Correlation with Renal Biopsy Observations

  2014cites this paper
• An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes.

  2014cites this paper
• Mesangial cells as amyloid factory: a unique contribution of animal models.

  2014cites this paper
• Immunoglobulin Free Light Chains and GAGs Mediate Multiple Myeloma Extracellular Vesicles Uptake and Secondary NfκB Nuclear Translocation

  2014cites this paper
• C-src Enriched Serum Microvesicles Are Generated in Malignant Plasma Cell Dyscrasia

  2013cites this paper
• Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes

  2013cites this paper
• Kidney disease and multiple myeloma.

  2013cites this paper
• A patient with persistent renal AL amyloid deposition after clinical remission by HDM/SCT therapy.

  2013cites this paper
• Amyloid formation in light chain amyloidosis.

  2013cites this paper
• Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.

  2013cites this paper
• Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment

  2012cites this paper
• The biology of immunoglobulin free light chains in kidney disease: a study of Monoclonal and Polyclonal light chains

  2012influential citation
• What do I need to know about immunoglobulin light chain (AL) amyloidosis?

  2012cites this paper
• Onco-nephrology: glomerular diseases with cancer.

  2012cites this paper
• Toward Personalized Medicine: The potential role of RNA interference in Plasma Cell Dyscrasia

  2011cites this paper
• Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases.

  2011cites this paper
• Amyloidosis - Mechanisms and Prospects for Therapy

  2011cites this paper
• Scanning/transmission electron microscopy to study how amyloid fibrils are extruded into the matrix

  2011cites this paper
• Animal model of renal AL-amyloidogenesis recapitulates in vitro findings

  2011cites this paper
• Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains.

  2011cites this paper
• Mesangial homeostasis and pathobiology: their role in health and disease.

  2011cites this paper
• Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.

  2011cites this paper
• Renal amyloidosis: current views on pathogenesis and impact on diagnosis.

  2011cites this paper
• The biology of immunoglobulin free light chains and kidney injury.

  2011cites this paper
• Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease.

  2010cites this paper
• Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture

  2010cites this paper
• Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.

  2010cites this paper
• Kidney disease associated with plasma cell dyscrasias.

  2010cites this paper
• Light chain amyloidosis - current findings and future prospects.

  2009cites this paper
• [Renal monoclonal immunoglobuline deposition disease as a rare variant of renal damage in multiple myeloma].

  2009cites this paper
• Free light chains in plasma of patients with light chain amyloidosis and non‐amyloid light chain deposition disease. High proportion and heterogeneity of disulfide‐linked monoclonal free light chains as pathogenic features of amyloid disease

  2009cites this paper
• Immunotactoid Microtubular Corneal Deposits in Bilateral Paraprotein Crystalline Keratopathy

  2009cites this paper
• Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains

  2008cites this paper
• The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA.

  2008cites this paper
• Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases.

  2008cites this paper
• Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties

  2008cites this paper
• Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

  2008influential citation
• Human matrix metalloproteinases: Characteristics and pathologic role in altering mesangial homeostasis

  2008cites this paper
• Renal manifestations of plasma cell disorders.

  2007cites this paper
• Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins.

  2007cites this paper
• Immunoglobulin light chains generate hydrogen peroxide.

  2007cites this paper
• Mechanisms of renal damage in plasma cell dyscrasias: an overview.

  2007cites this paper
• Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation.

  2007cites this paper
• Glomerular nephrotoxicity of aminoglycosides.

  2007cites this paper
• Role of translational research advancing the understanding of the pathogenesis of light chain‐mediated glomerulopathies

  2007cites this paper
• Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.

  2007cites this paper
• Plasticity of Mesangial Cells: A Basis for Understanding Pathological Alterations

  2006cites this paper
• Dangerous small B-cell clones.

  2006cites this paper
• Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts.

  2006cites this paper
• Disease of the Month Multiple Myeloma

  2006cites this paper
• Amyloidosis-associated kidney disease.

  2006cites this paper
• Disease of the Month Amyloidosis-Associated Kidney Disease

  2006cites this paper
• The ultrastructural basis of renal pathology in monoclonal gammopathies.

  2005cites this paper
• Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.

  2005cites this paper
• Lambda light chain deposition disease in a renal allograft.

  2005cites this paper
• Clinical aspects of systemic amyloid diseases.

  2005cites this paper
• Cellular response of cardiac fibroblasts to amyloidogenic light chains.

  2005cites this paper
• AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells

  2004cites this paper
• An Atypical Case of POEMS Syndrome with IgG Kappa M Protein and End Stage Renal Failure

  2004cites this paper